TDAC$10.820.28%-0.03
Translational Development Acquisition Corp (TDAC)
Date: 2026-10-30 16:00O: 10.82H: 10.84L: 10.81C: 10.82Vol: 18.04k
Translational Development Acquisition Corp stock is traded at $10.82, with a volume of 18,039. It is down -0.28% in the last 24 hours and down -0.09% over the past month. Translational Development Acquisition Corp is a newly organized blank check company.
Previous Close:
$10.85
Open:
$10.82
24h Volume:
18,039
Relative Volume:
2.65
Market Cap:
$208.92M
Revenue:
-
Net Income/Loss:
$6.21M
P/E Ratio:
38.17
EPS:
$0.2835
Net Cash Flow:
-$682.00K
1W Performance:
+0.09%
1M Performance:
-0.09%
6M Performance:
+1.79%
1Y Performance:
+3.54%
1-Day Range:
$10.81$10.84
1-Week Range:
$10.81$10.86
52-Week Range:
$10.09$10.95
Translational Development Acquisition Corp Stock (TDAC) Company Profile
Name
Translational Development Acquisition CorpSector
FinancialIndustry
Shell CompaniesPhone
(413) 204-2769Address
52 E 83RD ST., NEW YORK, USACompare TDAC vs VYLR, DMII, EVAC, BCSS, CEPF
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TDAC Translational Development Acquisition Corp | $10.82 | $208.92M | $0 | $6.21M | -$682.00K | $0.2835 |
 VYLR Vylor Inc. | $72.40 | $48.31B | $0 | $0 | $0 | $0.00 |
 DMII Drugs Made In America Acquisition Ii Corp | $10.20 | $649.74M | $0 | $8.58M | -$1.11M | $0.134 |
 EVAC Eqv Ventures Acquisition Corp Ii | $10.36 | $605.52M | $0 | $12.80M | -$714.00K | $0.2184 |
 BCSS Bain Capital Gss Investment Corp | $10.24 | $597.72M | $0 | $8.29M | -$686.50K | $0.142 |
 CEPF Cantor Equity Partners Iv Inc | $10.32 | $589.79M | $0 | $10.29M | -$337.90K | $0.1801 |
Translational Development Acquisition Corp Stock (TDAC) Upgrades & Downgrades
Translational Development Acquisition Corp Stock (TDAC) Financials Data
Revenue
Chart is being upgraded
This chart will be back soon.
